CPT Pharmacometrics & Systems Pharmacology · 2015 · 51 citations · 30 references
Public HealthBiostatisticsPharmacologyDrug DiscoveryMeta-analysisPharmacokinetic ModelingBayesian Meta-analysisModel Building
Meta-analysis is an increasingly important aspect of drug development as companies look to benchmark their own compounds with the competition. There is scope to carry out a wide range of analyses addressing key research questions from preclinical through to postregistration. This set of tutorials will take the reader through key model-based meta-analysis (MBMA) methods with this first installment providing a general introduction before concentrating on classical and Bayesian methods for landmark data.
30
Bias in meta-analysis detected by a simple, graphical test
Matthias Egger, George Davey Smith, Martin Schneider et al. · BMJ · 1997 · 56.3K citations
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff et al. · PubMed · 2009 · 45.1K citations · Full text
Quantifying heterogeneity in a meta‐analysis
Julian P. T. Higgins, Simon G. Thompson · Statistics in Medicine · 2002 · 36.7K citations